newsfilter
← Latest News
GlobeNewswire·

Biofrontera Inc. to Report Fourth Quarter and Full Year 2025 Financial Results and Host a Conference Call on March 19, 2026

  • Biofrontera Inc. will report financial results for the three months & full year ended December 31, 2025 after the U.S. market close on Thursday, March 19, 2026.
  • A conference call to discuss results & provide a business update will be held on Thursday, March 19, 2026 at 10:00 a.m. ET.
  • The event is accessible via U.S. phone line 1-888-222-5806, international line 1-412-902-6516, or the provided webcast link.
  • Biofrontera commercializes the drug-device combination Ameluz with the RhodoLED lamp series for photodynamic therapy of Actinic Keratosis.
  • The Company is conducting clinical trials to expand product use for non-melanoma skin cancers & moderate-to-severe acne.
  • Investor relations inquiries should be directed to Ben Shamsian at 646-829-9701 or shamsian@lythampartners.com.